Edition:
United States

Basilea Pharmaceutica AG (BSLN.S)

BSLN.S on Swiss Exchange

73.75CHF
8:17am EDT
Change (% chg)

CHF0.70 (+0.96%)
Prev Close
CHF73.05
Open
CHF73.20
Day's High
CHF73.95
Day's Low
CHF73.20
Volume
24,109
Avg. Vol
66,044
52-wk High
CHF87.10
52-wk Low
CHF63.75

Revenue & Earnings Per Share

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-18 3 115.70 129.50 104.00 104.85
Year Ending Dec-19 3 138.37 155.80 122.00 108.70
Earnings (per share)
Year Ending Dec-18 3 -1.77 -1.11 -2.43 -1.94
Year Ending Dec-19 2 -0.19 0.81 -1.20 -2.71
Sales and Profit Figures in Swiss Franc (CHF);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 222.84 32.59
P/E High - Last 5 Yrs. -- 281.48 47.07
P/E Low - Last 5 Yrs. -- 95.47 24.59
Beta 1.37 0.75 0.79
Price to Sales (TTM) 9.57 262.06 9.01
Price to Book (MRQ) -- 23.14 4.24
Price to Tangible Book (MRQ) -- 26.27 5.79
Price to Cash Flow (TTM) -- 127.68 21.78
% Owned Institutions -- 10.94 2.43

Dividends

  Company industry sector
Dividend Yield -- 0.30 1.66
Dividend Yield - 5 Year Avg 0.00 0.21 0.80
Dividend 5 Year Growth Rate -- 2.35 4.15
Payout Ratio(TTM) -- 46.91 17.73

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 40.19 26.86 5.10
Sales (TTM) vs TTM 1 Yr. Ago 39.42 150.04 12.65
Sales - 5 Yr. Growth Rate 9.39 30.10 8.10
EPS (MRQ) vs Qtr. 1 Yr. Ago 104.80 -158.81 33.25
EPS (TTM) vs TTM 1 Yr. Ago 64.72 -- --
EPS - 5 Yr. Growth Rate -- 46.66 8.54
Capital Spending - 5 Yr. Growth Rate -6.48 38.70 8.77

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 3.49 1.64 2.50
Current Ratio (MRQ) 3.69 6.54 3.56
LT Debt to Equity (MRQ) -- 22.23 12.86
Total Debt to Equity (MRQ) -- 25.74 15.83
Interest Coverage (TTM) -6.88 -177.44 35.15

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 90.05 33.95 54.64
Gross Margin - 5 Yr. Avg. -- 54.86 52.74
EBITD Margin (TTM) -13.39 -- --
EBITD - 5 Yr. Avg -62.72 -158.47 15.84
Operating Margin (TTM) -15.59 -930.08 -2.34
Operating Margin - 5 Yr. Avg. -66.92 -171.29 11.09
Pre-Tax Margin (TTM) -20.98 -814.97 -0.23
Pre-Tax Margin - 5 Yr. Avg. -70.84 -176.85 11.29
Net Profit Margin (TTM) -21.35 -806.24 -3.64
Net Profit Margin - 5 Yr. Avg. -71.12 -176.13 7.58
Effective Tax Rate (TTM) -- 14.58 31.25
Effective Tax Rate - 5 Yr. Avg. -- 18.23 24.61

Efficiency

  Company industry sector
Revenue/Employee (TTM) 394,235 21,442,083 721,262,098
Net Income/Employee (TTM) -84,174 -1,504,037 83,813,821
Receivable Turnover (TTM) 24.35 16.37 5.67
Inventory Turnover (TTM) 0.60 2.46 3.55
Asset Turnover (TTM) 0.27 0.42 0.85

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -5.70 -5.46 9.98
Return on Assets - 5 Yr. Avg. -12.56 -0.52 11.07
Return on Investment (TTM) -7.35 -7.75 12.60
Return on Investment - 5 Yr. Avg. -15.74 2.72 14.34
Return on Equity (TTM) -- -10.55 14.49
Return on Equity - 5 Yr. Avg. -147.00 -2.70 15.71
  1 Year 3 Year 5 Year
Sales % 39.42 28.74 9.39
EPS (TTM) % 64.77 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Basilea Pharmaceutica AG

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 7.43 5.83 99 40
13 Week 4.66 5.20 99 45
26 Week -3.63 -1.01 99 84
52 Week -7.24 -7.26 99 83
YTD -3.75 1.00 99 81
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 30.67%
# of Holders: 75
Total Shares Held: 3,642,222
3 Mo. Net Change: 32,300
# New Positions: 1
# Closed Positions: 3
# Increased Positions: 13
# Reduced Positions: 11
# Net Buyers: 2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.